No Attention-Boosting Drugs for Healthy Kids, Doctors Urge

Mar. 13, 2013 — The American Academy of Neurology (AAN), the world's largest professional association of neurologists, is releasing a position paper on how the practice of prescribing drugs to boost cognitive function, or memory and thinking abilities, in healthy children and teens is misguided

The statement is published in the March 13, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.
This growing trend, in which teens use "study drugs" before tests and parents request ADHD drugs for kids who don't meet the criteria for the disorder, has made headlines recently in the United States. The Academy has spent the past several years analyzing all of the available research and ethical issues to develop this official position paper.
"Doctors caring for children and teens have a professional obligation to always protect the best interests of the child, to protect vulnerable populations, and prevent the misuse of medication," said author William Graf, MD, of Yale University in New Haven, Conn., and a member of the American Academy of Neurology. "The practice of prescribing these drugs, called neuroenhancements, for healthy students is not justifiable."
The statement provides evidence that points to dozens of ethical, legal, social and developmental reasons why prescribing mind-enhancing drugs, such as those for ADHD, for healthy people is viewed differently in children and adolescents than it would be in functional, independent adults with full decision-making capacities. The Academy has a separate position statement that addresses the use of neuroenhancements in adults.
The article notes many reasons against prescribing neuroenhancement including: the child's best interest; the long-term health and safety of neuroenhancements, which has not been studied in children; kids and teens may lack complete decision-making capacities while their cognitive skills, emotional abilities and mature judgments are still developing; maintaining doctor-patient trust; and the risks of over-medication and dependency.
"The physician should talk to the child about the request, as it may reflect other medical, social or psychological motivations such as anxiety, depression or insomnia. There are alternatives to neuroenhancements available, including maintaining good sleep, nutrition, study habits and exercise regimens," said Graf.
The statement had no industry sponsors.

EXCERICISE REALLY WORKS.

WE HAD A MEDICAL STUDENT WHO COMPETED IN TRIATHALONS WHICH KEPT HIM IN CHECK, UNFORTUNATELY, DURING 120 HOUR WORK WEEK RESIDENCY TRAINING, HE DECOMPENSATED AND ALMOST GOT BOOTED OUT OF THE PROGRAM, HE WENT ON STRATTERA FOR THE REMAINING 3 YEARS, GOT HIS ACT TOGETHER, BUT HAD TO GIVE UP ASPIRATIONS OF VASCULAR SURGERY ( THEY AVERAGE 100 WORK WEEKS EVEN IN PRIVATE PRACTICE) AND BECAME A PATHOLOGIST SO HE COULD GO BACK TO EXCERCISING LIKE CRAZY.

THEY JUST SWAPPED MY DAUGHTERS MEDS FROM STRATTERA TO VYVANCE. WE WILL SEE HOW THIS WORKS...ID LOVE TO GET HER OFF ALL TOGETHER, BUT SHE NEEDS IT

WHEN I was doing neurophysiology research, we would compare PET scans of normal brains, Alzheimers and ADHD. The normal brain had red, blue, yellow lights and so did the Alzheimers except it was a different pattern. The ADHD brain was gray, all gray, no PET scan visible activity until it was given Adderal, then it looked exactly like the normal brain. Unfortunately, we can't PET scan someone excercising, but I bet it does the same thing. Remember, untreated ADD or ADHD in teenage drivers confers a 800 fold increase in car accidents. I would look to getting her off when she is in her young adult years and maybe encourage long distance type athletic activities.